Also known as Vitreous Syneresis
Vitreous degeneration is encountered rarely on Symcat. We will add more content to this page if enough people like you show interest.
Within all the people who go to their doctor with vitreous degeneration, 85% report having spots or clouds in vision, 71% report having diminished vision, and 34% report having symptoms of eye. The symptoms that are highly suggestive of vitreous degeneration are spots or clouds in vision, diminished vision, symptoms of eye, lacrimation, blindness, foreign body sensation in eye, bleeding from eye, double vision, and eye burns or stings, although you may still have vitreous degeneration without those symptoms.
Patients with vitreous degeneration often receive ophthalmic examination and evaluation, ophthalmologic and otologic diagnosis and treatment, diagnostic procedures on eye, repair of retinal tear; detachment, other intraocular therapeutic procedures, lens and cataract procedures, other therapeutic procedures on eyelids; conjunctiva; cornea and other extraocular muscle and orbit therapeutic procedures .
|Ophthalmic examination and evaluation (Eye exam)|
|Ophthalmologic and otologic diagnosis and treatment||$64|
|Diagnostic procedures on eye||$114|
|Repair of retinal tear; detachment||$2053|
|Other intraocular therapeutic procedures||$705|
|Lens and cataract procedures||$1016|
|Other therapeutic procedures on eyelids; conjunctiva; cornea||$962|
|Other extraocular muscle and orbit therapeutic procedures||$671|
The most commonly prescribed drugs for patients with vitreous degeneration include tropicamide ophthalmic, phenylephrine (duramax), latanoprost, benoxinate-fluorescein ophthalmic, prednisolone ophthalmic, proparacaine ophthalmic, loteprednol ophthalmic, nepafenac ophthalmic, cyclosporine ophthalmic, bevacizumab (avastin), loteprednol-tobramycin ophthalmic, prednisolone-sodium sulfacetamide ophthalmic and pilocarpine ophthalmic .
|Prednisolone-Sodium Sulfacetamide Ophthalmic|
Groups of people at highest risk for vitreous degeneration include age 75+ years age 60-74 years. On the other hand, age 1-4 years and age < 1 years almost never get vitreous degeneration.